Severe atopic dermatitis improved with identification and targeted therapy of cholinergic urticaria

Ann Allergy Asthma Immunol. 2023 May;130(5):671-672. doi: 10.1016/j.anai.2023.01.037. Epub 2023 Feb 8.

Authors

Ashley Y Wu¹, Jessica H Plager², Basil M Kahwash³

Affiliations

¹ Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
² Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
³ Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: basil.kahwash@vumc.org.

PMID: 36758940
DOI: 10.1016/j.anai.2023.01.037

No abstract available

MeSH terms

Cholinergic Agents
Dermatitis, Atopic* / drug therapy
Humans
Urticaria* / drug therapy

Substances

Cholinergic Agents